Event
September 30, 2026
18:15 - 19:45
Global Commission on Drug Policy 2026 Plenary Event
Global drug policy is at a crossroads. Across regions, approaches are increasingly diverging – from efforts to advance decriminalization and health-cantered responses to the continued reliance on punitive enforcement measures. These developments reflect wider political shifts around the world, including growing tensions between public health, security, and human rights approaches.
At the same time, the scale of drug use and related harms remains significant. An estimated 316 million people use drugs globally, while access to treatment and harm reduction services continues to fall far short of need. In many contexts, punitive approaches persist, contributing to mass incarceration, public health challenges, human rights concerns, and widening inequalities.
These dynamics have profound implications for the rule of law. Drug policy increasingly raises wider questions about democracy, public health, policing, inequality, and the role of the state.
Young people are particularly affected – both directly through criminalization and enforcement practices, and indirectly through the broader social and economic impacts on families, communities, and access to essential services. Yet their specific needs and rights remain insufficiently reflected in policy responses.
Held at the University of Geneva, this event will bring together perspectives from law, human rights, academia, and drug policy.
Open to students, academia, and the wider public, the discussion will examine how changing global dynamics are reshaping drug policy – and what fairer, more effective, and more realistic responses could look like in practice.
| 18.30 | Stephane Bussard, Journalist, Le Temps Introduction |
| 18.36 | Michel Kazatchkine, , Commissioner, Global Commission on Drug Policy, Former Executive Director of Global Fund to Fight AIDs, Tuberculosis and Malaria The Global Drug Policy Landscape: An overview of the current global drug policy landscape, examining how shifting political priorities, public health challenges, and evolving legal approaches are reshaping debates on drug control. |
| 18,42 | Ruby Lawlor, Executive Director, Youth RISE Why Youth Participation Matters in Drug Policy: A discussion on the role of young people in shaping drug policy, including the value of lived and living experience, barriers to meaningful participation, and how more inclusive approaches can lead to more relevant and sustainable policy responses. |
| 19.48 | TBC – Representative from the Office of the High Commissioner for Human Rights (OHCHR) Human Rights and Drug Policy: Reflections on the human rights implications of contemporary drug policies, with particular attention to equality, non-discrimination, and the rights of children and young people. |
| 18.54 | Barbara Broers, specialist in the clinical and public health aspects of addictions, University of Geneva (UNIGE) What the Evidence Tells Us: Drawing on research and clinical experience, this intervention will examine evidence on prevention, treatment, harm reduction, and public health, highlighting lessons from Switzerland and their relevance to international drug policy debates. |
| 19.00 | Questions and Answers with the audience |
| 19.56 | Stéphane Bussard, Journalist, Le Temps Closing remarks. |
| 10.00 | Cocktail of networking |
Registration is free but mandatory